Literature DB >> 18678837

An ideal prognostic test for estrogen receptor-positive breast cancer?

Soonmyung Paik, Gong Tang, Debora Fumagalli.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18678837     DOI： 10.1200/JCO.2008.16.7528

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  3 in total

1.  Physician survey of the effect of the 21-gene recurrence score assay results on treatment recommendations for patients with lymph node-positive, estrogen receptor-positive breast cancer.

Authors:  Ruth Oratz; Benjamin Kim; Calvin Chao; Stanley Skrzypczak; Caron Ory; Roberto Bugarini; Michael Broder
Journal:  J Oncol Pract       Date:  2011-03       Impact factor: 3.840

2.  Histopathological and genomic grading provide complementary prognostic information in breast cancer: a study on publicly available datasets.

Authors:  Nilotpal Chowdhury
Journal:  Patholog Res Int       Date:  2011-08-10

3.  Prognostic utility of the breast cancer index and comparison to Adjuvant! Online in a clinical case series of early breast cancer.

Authors:  Rachel C Jankowitz; Kristine Cooper; Mark G Erlander; Xiao-Jun Ma; Nicole C Kesty; Hongying Li; Mamatha Chivukula; Adam Brufsky
Journal:  Breast Cancer Res       Date:  2011-10-14       Impact factor: 6.466
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.